108 related articles for article (PubMed ID: 2941256)
1. On the differential affinities of two anticancer analogues to their target.
Holl E; Zänker KS; Lange J; Siewert JR
Drugs Exp Clin Res; 1985; 11(2):133-9. PubMed ID: 2941256
[TBL] [Abstract][Full Text] [Related]
2. [Locoregional chemotherapy of hepatic metastases of colorectal cancer].
Rougier P; Lasser P; Droz JP; Elias D; Ghosn M; Ducreux M; Lumbroso J; Sidibe S
Ann Gastroenterol Hepatol (Paris); 1987 Nov; 23(6):315-9. PubMed ID: 2962534
[TBL] [Abstract][Full Text] [Related]
3. The implantable "Infusaid" infusion pump. The Sydney experience using 5-fluorouracil.
Stephens FO; Crea P; Walker PJ
Med J Aust; 1986 Jan; 144(2):74-7. PubMed ID: 2934612
[TBL] [Abstract][Full Text] [Related]
4. Hepatic artery infusion of 5-FUDR after prior systemic 5-fluorouracil.
Buroker T; Samson M; Correa J; Fraile R; Vaitkevicius VK
Cancer Treat Rep; 1976 Sep; 60(9):1277-9. PubMed ID: 138480
[TBL] [Abstract][Full Text] [Related]
5. Fluorodeoxyuridine uptake by human colorectal hepatic metastases after hepatic artery infusion.
Sigurdson ER; Ridge JA; Daly JM
Surgery; 1986 Aug; 100(2):285-91. PubMed ID: 2943036
[TBL] [Abstract][Full Text] [Related]
6. Extrahepatic biliary stenoses after hepatic arterial infusion (HAI) of floxuridine (FUdR) for liver metastases from colorectal cancer.
Aldrighetti L; Arru M; Ronzoni M; Salvioni M; Villa E; Ferla G
Hepatogastroenterology; 2001; 48(41):1302-7. PubMed ID: 11677951
[TBL] [Abstract][Full Text] [Related]
7. Improved hepatic toxicity profile of portal vein adjuvant hepatic infusional chemotherapy.
Faynsod M; Wagman LD; Longmate J; Carroll M; Leong LA
J Clin Oncol; 2005 Aug; 23(22):4876-80. PubMed ID: 16009960
[TBL] [Abstract][Full Text] [Related]
8. A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil.
Ensminger WD; Rosowsky A; Raso V; Levin DC; Glode M; Come S; Steele G; Frei E
Cancer Res; 1978 Nov; 38(11 Pt 1):3784-92. PubMed ID: 151583
[No Abstract] [Full Text] [Related]
9. Pharmacokinetic studies of 5-fluorouracil and 5'-deoxy-5-fluorouridine in rats.
Au JL; Walker JS; Rustum Y
J Pharmacol Exp Ther; 1983 Oct; 227(1):174-80. PubMed ID: 6225866
[TBL] [Abstract][Full Text] [Related]
10. Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma.
Kemeny N; Eid A; Stockman J; Gonen M; Schwartz L; Tetzlaff E; Paty P
J Surg Oncol; 2005 Aug; 91(2):97-101. PubMed ID: 16028279
[TBL] [Abstract][Full Text] [Related]
11. Hepatic artery ligation or embolization and locoregional chemotherapy of liver metastases from colorectal cancer.
Gerard A; Pector JC; Bleiberg H
Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2351-4. PubMed ID: 3137873
[TBL] [Abstract][Full Text] [Related]
12. [Implanted percutaneous continuous hepatic arterial infusion system for nonresectable liver metastasis].
Zhu K; Shan H; Li Z
Zhonghua Zhong Liu Za Zhi; 2001 Nov; 23(6):493-6. PubMed ID: 11859719
[TBL] [Abstract][Full Text] [Related]
13. Intra-arterial infusion chemotherapy with 5-fluorouracil and cisplatin in advanced pancreatic cancer: a feasibility study.
Sasada T; Denno R; Tanaka T; Kanai M; Mizukami Y; Kohno S; Takabayashi A
Am J Clin Oncol; 2008 Feb; 31(1):71-8. PubMed ID: 18376231
[TBL] [Abstract][Full Text] [Related]
14. Steady-state nonlinear pharmacokinetics of 5-fluorouracil during hepatic arterial and intravenous infusions in cancer patients.
Wagner JG; Gyves JW; Stetson PL; Walker-Andrews SC; Wollner IS; Cochran MK; Ensminger WD
Cancer Res; 1986 Mar; 46(3):1499-506. PubMed ID: 3943107
[TBL] [Abstract][Full Text] [Related]
15. Hepatic arterial infusion of 5-fluorouracil for liver metastases from pancreatic carcinoma: results from a pilot study.
Furuse J; Maru Y; Yoshino M; Mera K; Sumi H; Tajiri H; Satake M; Onaya H; Ishikura S; Ogino T; Kawashima M; Ikeda H
Hepatogastroenterology; 2001; 48(37):208-11. PubMed ID: 11268967
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of 5-fluorouracil concentration in peripheral blood and side effects in continuous hepatic arterial infusion chemotherapy for patients with unresectable liver cancer].
Fujii K; Nakashima K; Ohno T; Anai H
Gan To Kagaku Ryoho; 1997 Sep; 24(12):1835-7. PubMed ID: 9382545
[TBL] [Abstract][Full Text] [Related]
17. Feasibility study of ambulatory continuous infusion of 5-fluorouracil followed by cisplatin through hepatic artery for metastatic colorectal cancer.
Qin B; Kato K; Mitsugi K; Nakamura M; Tanaka R; Baba E; Ariyama H; Kuroiwa T; Harada M; Nakano S
Cancer Chemother Pharmacol; 2006 Jan; 57(1):114-9. PubMed ID: 16001177
[TBL] [Abstract][Full Text] [Related]
18. Repeated hepatic intra-arterial chemotherapy based on results of anticancer drug sensitivity test in patients with synchronous hepatic metastases from colorectal cancer.
Matsuoka H; Nagaya M; Tsukikawa S; Yanagi Y; Isogai A; Kubota S
Surgery; 2006 Sep; 140(3):387-95. PubMed ID: 16934600
[TBL] [Abstract][Full Text] [Related]
19. Hepatic artery infusion using oxaliplatin in combination with 5-fluorouracil, folinic acid and mitomycin C: oxaliplatin pharmacokinetics and feasibility.
Guthoff I; Lotspeich E; Fester C; Wallin I; Schatz M; Ehrsson H; Kornmann M
Anticancer Res; 2003; 23(6D):5203-8. PubMed ID: 14981990
[TBL] [Abstract][Full Text] [Related]
20. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.
Ducreux M; Ychou M; Laplanche A; Gamelin E; Lasser P; Husseini F; Quenet F; Viret F; Jacob JH; Boige V; Elias D; Delperro JR; Luboinski M;
J Clin Oncol; 2005 Aug; 23(22):4881-7. PubMed ID: 16009952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
